Autek China Inc.

Equities

300595

CNE100002MR0

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
18.06 CNY +2.21% Intraday chart for Autek China Inc. +7.63% -20.02%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Autek China Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Autek China Inc. Announces Profit Distribution Proposal for 2023 CI
Nomura Adjusts Ovctek China’s Price Target to 22.16 Yuan From 25.69 Yuan, Keeps at Neutral MT
Autek China Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts Ovctek China's Price Target to 30.19 Yuan From 33.83 Yuan, Keeps at Neutral MT
Autek China Logs Double-Digit Earnings Growth in H1 MT
Autek China Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Autek China Elects Founder as Chairman, General Manager MT
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Shenzhen Mingmou Ruishi Eye Clinic from Zhao Xiaoting, and Li Xianting for CNY 20.7 million. CI
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Kunming Shikang Eye Clinic Co., Ltd. from Yunnan Shilikang Enterprise Management Partnership Enterprise (Limited Partnership), Zhang Mingjing, and Ouyang Zhonghua for CNY 58.2 million. CI
Autek China Inc. agreed to acquire an additional 30% stake in Xuancheng Autek Baixiu Medical Devices Co., Ltd. from Huang Guanglu and Liu Jihua for CNY 21.93 million CI
Autek China Inc. agreed to acquire an additional 38.99% stake in Xuancheng Mengdaiwei Medical Devices Co., Ltd. from Huangyan Yulu and Hu Chenying for CNY 21.15 million CI
Autek China Inc. entered into an agreement to acquire additional 39% stake in Quanzhou Autek Optical Technology Co., Ltd. from Zhuang Chaoyang, and Zheng Jing for approximately CNY 30 million. CI
Autek Investment Co., Ltd. entered into an agreement to acquire 39% stake in Suzhou Kangshi Health Eye Information Consulting Co., Ltd. from Yuan Lili and Sun Weiling for CNY 107 million. CI
Autek China Inc. agreed to acquire a 39% stake in Xiantao Jiashi Eye Clinic Co., Ltd. from Wang Tiehan for CNY 17.41 million CI
Autek China Inc. signed the share transfer agreement to acquire an additional 39% stake in Bengbu Autek Optical Equipment Technology Co., Ltd. from Shi Jing for CNY 45 million. CI
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Xuancheng Dental Hospital Co., Ltd. from Huang Chaohui, He Xiaoqing for CNY 16.3 million. CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Fuzhou Autek Medical Devices Co., Ltd. from Ye Xiaodan, Liao Lianming and Luo Dongming for CNY 20.4 million. CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Fuzhou Autek Medical Devices Co., Ltd. from Ye Xiaodan, Liao Lianming and Luo Dongming for approximately CNY 120 million. CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Jingjiang Autek Jingcheng Eye Health Service Co., Ltd. from Hou Aihua and Lu Hanxing for CNY 21.5 million. CI
Autek China Inc. Announces Final Dividend on A Shares for the Year 2022, Payable on May 16, 2023 CI
Autek China Inc. Approves Election of Xu Qiang Independent Director CI
Autek China Inc. Approves 2022 Profit Distribution Plan CI
Nomura Adjusts Autek China’s Price Target to 33.83 Yuan From 37.60 Yuan, Keeps at Neutral MT
Autek China Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chart Autek China Inc.
More charts
Autek China Inc is a China-based company principally engaged in the research and development, production and sales of eye-sight products and the provision of eye-sight services. The Company's main business is non-surgical vision correction. The Company's main products include orthokeratology, general contact lens and care products. Its core product is Dream David orthokeratology. In addition, The Company is also engaged in general glass frame sales business. The Company mainly operates its business in the domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.06 CNY
Average target price
24.85 CNY
Spread / Average Target
+37.61%
Consensus
  1. Stock Market
  2. Equities
  3. 300595 Stock
  4. News Autek China Inc.
  5. Autek China Elects Founder as Chairman, General Manager